J Thorac Cardiovasc Surg 2005;130:1480-1481
© 2005 The American Association for Thoracic Surgery
Whatever the approach, cutting strut chordae would not smell as sweet
Mathias H. Aazami, MD,
Mehrdad Salehi, MD,
Roya Satarzadeh, MD
Department of Cardiac Surgery and Thoracic Transplantation, Tehran University of Medical Sciences, Tehran, Iran
| The first 20% of the full text of this article appears below. |
To the Editor:
With the first clinical application of Messas and colleagues' ovine trial,
1
Fayad and colleagues
2
reported the case of a patient with chronic ischemic mitral regurgitation (CIMR) who was managed successfully with strut chordae severing through an exclusive aortotomy and concomitant coronary artery bypass grafting. Although encouraging midterm results were reported, the objection can be raised to the authors' rationale of a "cut-and-go" approach in the face of such a complex pathophysiologic entity. As indicated by the authors, the factors involved in the genesis of CIMR are multiple and intricate, reflecting the complexity in preoperative analysis of CIMR mechanisms attempted . . . [Full Text of this Article]
Related Article
-
J. Thorac. Cardiovasc. Surg. 2005 130: 1235-e6.
Copyright © 2005 by The American Association for Thoracic Surgery.